Sales of Cananbis and Seeds Clones Are Growing Rapidly in Germany

On April 1st, 2024, Germany made history by becoming the largest European country to introduce nationwide legalization of cannabis use by adults. From that date, German adults can legally grow, possess and consume cannabis.

This landmark step is of great importance, not only for the people of Germany, but also for the whole of Europe, as Germany has pioneered cannabis legislation on such a large scale.

Popularity of cannabis clones and seeds in Germany

YouGov research shows that hemp clones and seeds have been very popular since legalization. The statistics are clear: 7% of German adults have purchased hemp clones or seeds since April 1st, 2024. It is worth noting that this popularity is particularly high among young adults – as many as 14% of people aged 18-34 have made such a purchase.

In contrast, only 2% of Germans over 55 years of age decided to purchase hemp clones or seeds. This data suggests a significant increase in interest in growing cannabis among the younger population.

Cannabis clone and seed market

Based on the German adult population of approximately 70 million, the number of potential customers in the cannabis clone and seed market can be estimated. Assuming that 7% of German adults have purchased these products since legalization, we are talking about approximately 4.9 million people.

The future of this market seems promising, especially in the context of the development of cannabis clubs, which may become the main sources of clones and seeds. These clubs will not only provide products, but also promote the genetic diversity of cannabis and support the development of personal crops among enthusiasts.

The legalization of cannabis in Germany has not only stimulated the recreational market, but also created synergies with the medical market. The increase in hemp cultivation for both recreational and medical purposes will support each other, contributing to the overall development of the hemp industry in the country. This synergy leads to increased investment in cultivation technologies, improved product quality and expanded knowledge and skills in the field of hemp cultivation.

The introduction of cannabis legalization in Germany on April 1, 2024 has become an important step in the country’s history, affecting both the recreational and medical markets. The popularity of cannabis clones and seeds is growing rapidly, especially among young adults. This market is expected to continue to grow, driven by the growing number of cannabis clubs and the growing demand for cannabis products and services.

Future forecasts indicate that the cannabis market in Germany will grow rapidly, creating new business opportunities, investments and jobs, while providing high-quality products for both recreational and medical users.

__

(Featured image by Terrance Barksdale via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.